Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Neurodevelopment: The Impact of Nutrition and Inflammation During Preconception and Pregnancy in Low-Resource Settings.

Vohr BR, Poggi Davis E, Wanke CA, Krebs NF.

Pediatrics. 2017 Apr;139(Suppl 1):S38-S49. doi: 10.1542/peds.2016-2828F. Review.

2.

Longitudinal Analysis of the Intestinal Microbiota in Persistently Stunted Young Children in South India.

Dinh DM, Ramadass B, Kattula D, Sarkar R, Braunstein P, Tai A, Wanke CA, Hassoun S, Kane AV, Naumova EN, Kang G, Ward HD.

PLoS One. 2016 May 26;11(5):e0155405. doi: 10.1371/journal.pone.0155405. eCollection 2016.

3.

Switch to Raltegravir From Protease Inhibitor or Nonnucleoside Reverse-Transcriptase Inhibitor Does not Reduce Visceral Fat In Human Immunodeficiency Virus-Infected Women With Central Adiposity.

Lake JE, McComsey GA, Hulgan T, Wanke CA, Mangili A, Walmsley SL, Currier JS.

Open Forum Infect Dis. 2015 Apr 26;2(2):ofv059. doi: 10.1093/ofid/ofv059. eCollection 2015 Apr.

4.

Cardiovascular Disease-Risk Markers in HIV Patients.

Asztalos BF, Matera R, Horvath KV, Horan M, Tani M, Polak JF, Skinner S, Wanke CA.

J AIDS Clin Res. 2014 Jun 12;5(7). pii: 317.

5.

Toxicity and clinical outcomes in patients with HIV on zidovudine and tenofovir based regimens: a retrospective cohort study.

Thuppal SV, Wanke CA, Noubary F, Cohen JT, Mwamburi M, Ooriapdickal AC, Muliyil J, Kang G, Varghese GM, Rupali P, Karthik R, Sathasivam R, Clarance P, Pulimood SA, Peter D, George L.

Trans R Soc Trop Med Hyg. 2015 Jun;109(6):379-85. doi: 10.1093/trstmh/trv016. Epub 2015 Mar 15.

6.

Nutrition assessment, counseling, and support interventions to improve health-related outcomes in people living with HIV/AIDS: a systematic review of the literature.

Tang AM, Quick T, Chung M, Wanke CA.

J Acquir Immune Defic Syndr. 2015 Apr 15;68 Suppl 3:S340-9. doi: 10.1097/QAI.0000000000000521. Review.

7.

Intestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infection.

Dinh DM, Volpe GE, Duffalo C, Bhalchandra S, Tai AK, Kane AV, Wanke CA, Ward HD.

J Infect Dis. 2015 Jan 1;211(1):19-27. doi: 10.1093/infdis/jiu409. Epub 2014 Jul 23.

8.

Urinary eicosanoid metabolites in HIV-infected women with central obesity switching to raltegravir: an analysis from the women, integrase, and fat accumulation trial.

Hulgan T, Boger MS, Liao DH, McComsey GA, Wanke CA, Mangili A, Walmsley SL, McCreath H, Milne GL, Sanchez SC, Currier JS, Lake JE.

Mediators Inflamm. 2014;2014:803095. doi: 10.1155/2014/803095. Epub 2014 Jun 1.

9.

Short communication: effects of omega-3 fatty acids on triglycerides and high-density lipoprotein subprofiles in HIV-infected persons with hypertriglyceridemia.

Paranandi A, Asztalos BF, Mangili A, Kuvin J, Gerrior J, Sheehan H, Skinner SC, Tang AM, Wanke CA.

AIDS Res Hum Retroviruses. 2014 Aug;30(8):800-5. doi: 10.1089/AID.2014.0005.

10.

High-fat meals do not impair postprandial endothelial function in HIV-infected and uninfected men.

Volpe GE, Wanke CA, Imai CM, Heffernan KS, Kuvin JT, Mangili A.

AIDS Res Hum Retroviruses. 2014 Sep;30(9):881-7. doi: 10.1089/AID.2013.0272. Epub 2014 Jun 26.

11.

Switch to raltegravir decreases soluble CD14 in virologically suppressed overweight women: the Women, Integrase and Fat Accumulation Trial.

Lake JE, McComsey GA, Hulgan T, Wanke CA, Mangili A, Walmsley SL, Stramotas SA, Tracy R, Currier JS.

HIV Med. 2014 Aug;15(7):431-41. doi: 10.1111/hiv.12128. Epub 2014 Feb 10.

12.

Immune response and intestinal permeability in children with acute gastroenteritis treated with Lactobacillus rhamnosus GG: a randomized, double-blind, placebo-controlled trial.

Sindhu KN, Sowmyanarayanan TV, Paul A, Babji S, Ajjampur SS, Priyadarshini S, Sarkar R, Balasubramanian KA, Wanke CA, Ward HD, Kang G.

Clin Infect Dis. 2014 Apr;58(8):1107-15. doi: 10.1093/cid/ciu065. Epub 2014 Feb 5.

13.

Lipoprotein-associated phospholipase A2, a novel cardiovascular inflammatory marker, in HIV-infected patients.

Mangili A, Ahmad R, Wolfert RL, Kuvin J, Polak JF, Karas RH, Wanke CA.

Clin Infect Dis. 2014 Mar;58(6):893-900. doi: 10.1093/cid/cit815. Epub 2013 Dec 11.

14.

Cost estimation of first-line antiretroviral therapy with zidovudine/stavudine as the nucleoside backbone in India: a pilot study.

Thuppal SV, Karthik R, Abraham OC, Wanke CA, Mwamburi M, Terrin N, Cohen JT, Mathai D, Muliyil J, Kang G.

J Int Assoc Provid AIDS Care. 2015 Mar-Apr;14(2):180-4. doi: 10.1177/2325957413500530. Epub 2013 Sep 11.

PMID:
24027170
15.

Progression of carotid intima-media thickness and coronary artery calcium over 6 years in an HIV-infected cohort.

Volpe GE, Tang AM, Polak JF, Mangili A, Skinner SC, Wanke CA.

J Acquir Immune Defic Syndr. 2013 Sep 1;64(1):51-7. doi: 10.1097/QAI.0b013e31829ed726.

16.

Metabolic syndrome predicts all-cause mortality in persons with human immunodeficiency virus.

Jarrett OD, Wanke CA, Ruthazer R, Bica I, Isaac R, Knox TA.

AIDS Patient Care STDS. 2013 May;27(5):266-71. doi: 10.1089/apc.2012.0402.

17.

Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons.

Rotger M, Glass TR, Junier T, Lundgren J, Neaton JD, Poloni ES, van 't Wout AB, Lubomirov R, Colombo S, Martinez R, Rauch A, Günthard HF, Neuhaus J, Wentworth D, van Manen D, Gras LA, Schuitemaker H, Albini L, Torti C, Jacobson LP, Li X, Kingsley LA, Carli F, Guaraldi G, Ford ES, Sereti I, Hadigan C, Martinez E, Arnedo M, Egaña-Gorroño L, Gatell JM, Law M, Bendall C, Petoumenos K, Rockstroh J, Wasmuth JC, Kabamba K, Delforge M, De Wit S, Berger F, Mauss S, de Paz Sierra M, Losso M, Belloso WH, Leyes M, Campins A, Mondi A, De Luca A, Bernardino I, Barriuso-Iglesias M, Torrecilla-Rodriguez A, Gonzalez-Garcia J, Arribas JR, Fanti I, Gel S, Puig J, Negredo E, Gutierrez M, Domingo P, Fischer J, Fätkenheuer G, Alonso-Villaverde C, Macken A, Woo J, McGinty T, Mallon P, Mangili A, Skinner S, Wanke CA, Reiss P, Weber R, Bucher HC, Fellay J, Telenti A, Tarr PE; MAGNIFICENT Consortium; INSIGHT; Swiss HIV Cohort Study.

Clin Infect Dis. 2013 Jul;57(1):112-21. doi: 10.1093/cid/cit196. Epub 2013 Mar 26.

18.

Racial differences in central hemodynamic burden in men with HIV: preliminary findings.

Heffernan KS, Wanke CA, Dong K, Warner PJ, Anskat PE, Karas RH, Kuvin JT.

Ethn Dis. 2013 Spring;23(2):217-22.

PMID:
23530304
19.

Pharmacy and self-report adherence measures to predict virological outcomes for patients on free antiretroviral therapy in Tamil Nadu, India.

McMahon JH, Manoharan A, Wanke CA, Mammen S, Jose H, Malini T, Kadavanu T, Jordan MR, Elliott JH, Lewin SR, Mathai D.

AIDS Behav. 2013 Jul;17(6):2253-9. doi: 10.1007/s10461-013-0436-x.

20.

A randomized trial of Raltegravir replacement for protease inhibitor or non-nucleoside reverse transcriptase inhibitor in HIV-infected women with lipohypertrophy.

Lake JE, McComsey GA, Hulgan TM, Wanke CA, Mangili A, Walmsley SL, Boger MS, Turner RR, McCreath HE, Currier JS.

AIDS Patient Care STDS. 2012 Sep;26(9):532-40. doi: 10.1089/apc.2012.0135. Epub 2012 Jul 23.

21.

HIV infection and progression of carotid and coronary atherosclerosis: the CARE study.

Mangili A, Polak JF, Skinner SC, Gerrior J, Sheehan H, Harrington A, Wanke CA.

J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):148-53. doi: 10.1097/QAI.0b013e31822d4993.

PMID:
21792061
22.

Predictors of Weight Change in Male HIV-Positive Injection Drug Users Initiating Antiretroviral Therapy in Hanoi, Vietnam.

Tang AM, Sheehan HB, Jordan MR, Duong DV, Terrin N, Dong K, Lien TT, Trung NV, Wanke CA, Hien ND.

AIDS Res Treat. 2011;2011:890308. doi: 10.1155/2011/890308. Epub 2011 Jul 6.

23.

Repeated assessments of food security predict CD4 change in the setting of antiretroviral therapy.

McMahon JH, Wanke CA, Elliott JH, Skinner S, Tang AM.

J Acquir Immune Defic Syndr. 2011 Sep 1;58(1):60-3. doi: 10.1097/QAI.0b013e318227f8dd.

24.

Malnutrition in a population of HIV-positive and HIV-negative drug users living in Chennai, South India.

Tang AM, Bhatnagar T, Ramachandran R, Dong K, Skinner S, Kumar MS, Wanke CA.

Drug Alcohol Depend. 2011 Oct 1;118(1):73-7. doi: 10.1016/j.drugalcdep.2011.02.020. Epub 2011 Mar 21.

25.

Pilot randomized trial of nutritional supplementation in patients with tuberculosis and HIV-tuberculosis coinfection receiving directly observed short-course chemotherapy for tuberculosis.

Sudarsanam TD, John J, Kang G, Mahendri V, Gerrior J, Franciosa M, Gopal S, John KR, Wanke CA, Muliyil J.

Trop Med Int Health. 2011 Jun;16(6):699-706. doi: 10.1111/j.1365-3156.2011.02761.x. Epub 2011 Mar 21.

26.

Framingham risk score and early markers of atherosclerosis in a cohort of adults infected with HIV.

Falcone EL, Mangili A, Skinner S, Alam A, Polak JF, Wanke CA.

Antivir Ther. 2011;16(1):1-8. doi: 10.3851/IMP1682.

PMID:
21311103
27.

Pharmacy adherence measures to assess adherence to antiretroviral therapy: review of the literature and implications for treatment monitoring.

McMahon JH, Jordan MR, Kelley K, Bertagnolio S, Hong SY, Wanke CA, Lewin SR, Elliott JH.

Clin Infect Dis. 2011 Feb 15;52(4):493-506. doi: 10.1093/cid/ciq167. Epub 2011 Jan 18.

28.

Markers of atherosclerosis and inflammation and mortality in patients with HIV infection.

Mangili A, Polak JF, Quach LA, Gerrior J, Wanke CA.

Atherosclerosis. 2011 Feb;214(2):468-73. doi: 10.1016/j.atherosclerosis.2010.11.013. Epub 2010 Nov 17.

29.

Nutrition issues in the HIV-infected injection drug user: findings from the nutrition for healthy living cohort.

Hendricks KM, Erzen HD, Wanke CA, Tang AM.

J Am Coll Nutr. 2010 Apr;29(2):136-43.

PMID:
20679149
30.

Nutritional supplementation in HIV-infected individuals in South India: a prospective interventional study.

Swaminathan S, Padmapriyadarsini C, Yoojin L, Sukumar B, Iliayas S, Karthipriya J, Sakthivel R, Gomathy P, Thomas BE, Mathew M, Wanke CA, Narayanan PR.

Clin Infect Dis. 2010 Jul 1;51(1):51-7. doi: 10.1086/653111.

PMID:
20509768
31.

Micronutrient concentrations and subclinical atherosclerosis in adults with HIV.

Falcone EL, Mangili A, Tang AM, Jones CY, Woods MN, Polak JF, Wanke CA.

Am J Clin Nutr. 2010 May;91(5):1213-9. doi: 10.3945/ajcn.2009.28816. Epub 2010 Mar 10.

32.

Effect of a dietary intervention and n-3 fatty acid supplementation on measures of serum lipid and insulin sensitivity in persons with HIV.

Woods MN, Wanke CA, Ling PR, Hendricks KM, Tang AM, Knox TA, Andersson CE, Dong KR, Skinner SC, Bistrian BR.

Am J Clin Nutr. 2009 Dec;90(6):1566-78. doi: 10.3945/ajcn.2009.28137. Epub 2009 Oct 21.

33.

Knowledge, beliefs, and health care practices relating to treatment of HIV in Vellore, India.

Chomat AM, Wilson IB, Wanke CA, Selvakumar A, John KR, Isaac R.

AIDS Patient Care STDS. 2009 Jun;23(6):477-84. doi: 10.1089/apc.2008.0222.

34.

Metabolic syndrome and serum fatty acid patterns in serum phospholipids in hypertriglyceridemic persons with human immunodeficiency virus.

Woods MN, Wanke CA, Ling PR, Hendricks KM, Tang AM, Andersson CE, Dong KR, Sheehan HM, Bistrian BR.

Am J Clin Nutr. 2009 Apr;89(4):1180-7. doi: 10.3945/ajcn.2009.27444. Epub 2009 Feb 25.

35.

Ritonavir greatly impairs CYP3A activity in HIV infection with chronic viral hepatitis.

Knox TA, Oleson L, von Moltke LL, Kaufman RC, Wanke CA, Greenblatt DJ.

J Acquir Immune Defic Syndr. 2008 Dec 1;49(4):358-68.

PMID:
19186349
36.

Dietary patterns and health and nutrition outcomes in men living with HIV infection.

Hendricks KM, Mwamburi DM, Newby PK, Wanke CA.

Am J Clin Nutr. 2008 Dec;88(6):1584-92. doi: 10.3945/ajcn.2008.26098.

37.

Screening and assessment of coronary heart disease in HIV-infected patients.

Hsue PY, Squires K, Bolger AF, Capili B, Mensah GA, Temesgen Z, Wanke CA, Wohl DA; Working Group 4.

Circulation. 2008 Jul 8;118(2):e41-7. doi: 10.1161/CIRCULATIONAHA.107.189626. Epub 2008 Jun 19. No abstract available.

PMID:
18566317
38.

Drug use and other risk factors related to lower body mass index among HIV-infected individuals.

Quach LA, Wanke CA, Schmid CH, Gorbach SL, Mwamburi DM, Mayer KH, Spiegelman D, Tang AM.

Drug Alcohol Depend. 2008 May 1;95(1-2):30-6. doi: 10.1016/j.drugalcdep.2007.12.004. Epub 2008 Feb 19.

39.

Dietary supplement use and nutrient intake in HIV-infected persons.

Hendricks KM, Sansavero M, Houser RF, Tang AM, Wanke CA.

AIDS Read. 2007 Apr;17(4):211-6, 223-7.

PMID:
17479507
40.

Metabolic syndrome and subclinical atherosclerosis in patients infected with HIV.

Mangili A, Jacobson DL, Gerrior J, Polak JF, Gorbach SL, Wanke CA.

Clin Infect Dis. 2007 May 15;44(10):1368-74. Epub 2007 Apr 5.

41.

Risk of cardiovascular disease in a cohort of HIV-infected adults: a study using carotid intima-media thickness and coronary artery calcium score.

Mangili A, Gerrior J, Tang AM, O'Leary DH, Polak JK, Schaefer EJ, Gorbach SL, Wanke CA.

Clin Infect Dis. 2006 Dec 1;43(11):1482-9. Epub 2006 Oct 31.

PMID:
17083026
42.

Dietary glycemic index of human immunodeficiency virus-positive men with and without fat deposition.

Dong KR, Wanke CA, Tang AM, Ding B, Hendricks KM.

J Am Diet Assoc. 2006 May;106(5):728-32.

PMID:
16647332
43.

Nutrition and HIV infection: review of weight loss and wasting in the era of highly active antiretroviral therapy from the nutrition for healthy living cohort.

Mangili A, Murman DH, Zampini AM, Wanke CA.

Clin Infect Dis. 2006 Mar 15;42(6):836-42. Epub 2006 Feb 7. Review.

PMID:
16477562
44.

Multilocus genotyping of Cryptosporidium sp. isolates from human immunodeficiency virus-infected individuals in South India.

Muthusamy D, Rao SS, Ramani S, Monica B, Banerjee I, Abraham OC, Mathai DC, Primrose B, Muliyil J, Wanke CA, Ward HD, Kang G.

J Clin Microbiol. 2006 Feb;44(2):632-4.

45.

Body composition in adults infected with human immunodeficiency virus in Khon Kaen, Thailand.

Ludy MJ, Hendricks K, Houser R, Chetchotisakd P, Mootsikapun P, Anunnatsiri S, Price E, Wanke CA.

Am J Trop Med Hyg. 2005 Oct;73(4):815-9.

PMID:
16222031
46.

Combination megestrol acetate, oxandrolone, and dietary advice restores weight in human immunodeficiency virus.

Mwamburi DM, Gerrior J, Wilson IB, Chang H, Scully E, Saboori S, Miller L, Forfia J, Albrecht M, Wanke CA.

Nutr Clin Pract. 2004 Aug;19(4):395-402.

PMID:
16215131
47.

Predicting CD4 count using total lymphocyte count: a sustainable tool for clinical decisions during HAART use.

Mwamburi DM, Ghosh M, Fauntleroy J, Gorbach SL, Wanke CA.

Am J Trop Med Hyg. 2005 Jul;73(1):58-62.

PMID:
16014833
48.

Understanding the role of HIV load in determining weight change in the era of highly active antiretroviral therapy.

Mwamburi DM, Wilson IB, Jacobson DL, Spiegelman D, Gorbach SL, Knox TA, Wanke CA.

Clin Infect Dis. 2005 Jan 1;40(1):167-73. Epub 2004 Dec 8.

PMID:
15614708
49.

Analysis of generic antiretroviral formulations manufactured in India.

Ramachandran G, Perloff ES, von Moltke LL, Swaminathan S, Wanke CA, Greenblatt DJ.

AIDS. 2004 Jul 2;18(10):1482-4. No abstract available.

PMID:
15199331
50.

Comparing megestrol acetate therapy with oxandrolone therapy for HIV-related weight loss: similar results in 2 months.

Mwamburi DM, Gerrior J, Wilson IB, Chang H, Scully E, Saboori S, Miller L, Forfia J, Albrecht M, Wanke CA.

Clin Infect Dis. 2004 Mar 15;38(6):895-902. Epub 2004 Mar 1.

PMID:
14999637

Supplemental Content

Loading ...
Support Center